Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years

Maija Heiro, Hans Helenius, Saija Hurme, Timo Savunen, Kaj Metsärinne, Erik Engblom, Jukka Nikoskelainen, Pirkko Kotilainen, Maija Heiro, Hans Helenius, Saija Hurme, Timo Savunen, Kaj Metsärinne, Erik Engblom, Jukka Nikoskelainen, Pirkko Kotilainen

Abstract

Background: Only a few previous studies have focused on the long-term prognosis of the patients with infective endocarditis (IE). Our purpose was to delineate factors potentially associated with the long-term outcome of IE, recurrences of IE and requirement for late valve surgery.

Methods: A total of 326 episodes of IE in 303 patients were treated during 1980-2004 in the Turku University Hospital. We evaluated the long-term outcome and requirement for late valve surgery for 243 of these episodes in 226 patients who survived longer than 1 year after the initial admission. Factors associated with recurrences were analysed both for the 1-year survivors and for all 303 patients.

Results: The mean (SD) follow-up time for the 1-year survivors was 11.5 (7.3) years (range 25 days to 25.5 years). The overall survival was 95%, 82%, 66%, 51% and 45% at 2, 5, 10, 15 and 20 years. In age and sex adjusted multivariate analyses, significant predictors for long-term overall mortality were heart failure within 3 months of admission (HR 1.97, 95% CI 1.27 to 3.06; p = 0.003) and collagen disease (HR 2.54, 95% CI 1.25 to 5.19; p = 0.010) or alcohol abuse (HR 2.39, 95% CI 1.30 to 4.40; p = 0.005) as underlying conditions, while early surgery was significantly associated with lower overall mortality rates (HR 0.31, 95% CI 0.17 to 0.58; p < 0.001). Heart failure was also significantly associated with the long-term cardiac mortality (p = 0.032). Of all 303 patients, 20 had more than 1 disease episode. Chronic dialysis (p = 0.002), intravenous drug use (p = 0.002) and diabetes (p = 0.015) were significant risk factors for recurrent episodes of IE, but when analysed separately for the 1-year survivors, only chronic dialysis remained significant (p = 0.017). Recurrences and late valve surgery did not confer a poor prognosis.

Conclusion: Heart failure during the index episode of IE was the complication, which significantly predicted a poor long-term outcome. Patients who underwent surgery during the initial hospitalisation for IE faired significantly better than those who did not.

Figures

Figure 1
Figure 1
Kaplan-Meier curves of the overall mortality and cardiac mortality for 243 episodes of infective endocarditis in 226 patients, who survived longer than 1 year after the initial episode. The numbers at different time points refer to the number of patients being followed up and at risk for event at the beginning of the time period. Zero on the time access indicates 1 year.
Figure 2
Figure 2
Long-term outcome was analysed for 243 episodes of infective endocarditis in 226 patients, who survived longer than 1 year after the initial episode. Kaplan-Meier curves of the overall survival for patients with and without heart failure during 3 months of admission (a), and for those undergoing and not undergoing early (in-hospital) surgery (b). The numbers at different time points refer to the number of patients being followed up and at risk for event at the beginning of the following time period. Zero on the time access indicates 1 year.
Figure 3
Figure 3
Kaplan-Meier curves of survival free of recurrent endocarditis, valve replacement, and death after an episode of infective endocarditis. The numbers at different time points refer to the number of patients being followed up and at risk for event at the beginning of the following time period. Zero on the time access indicates 1 year.

References

    1. Netzer ROM, Zollinger E, Seiler C, Cerny A. Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980–1995. Heart. 2000;84:25–30. doi: 10.1136/heart.84.1.25.
    1. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90–94. doi: 10.1001/archinte.162.1.90.
    1. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88:53–60. doi: 10.1136/heart.88.1.53.
    1. Chu VH, Cabell CH, Benjamin DK, Kuniholm EF, Fowler VG, Engemann J, Sexton DJ, Corey GR, Wang A. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109:1745–1749. doi: 10.1161/01.CIR.0000124719.61827.7F.
    1. Tornos P, Almirante B, Olona M, Permanyer G, González T, Carballo J, Pahissa A, Soler-Soler J. Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience. Clin Infect Dis. 1997;24:381–386.
    1. Castillo JC, Anguita MP, Ruiz M, Delgado M, Mesa D, Romo E, Arizón JM, Vallés F. Clinical features and outcome of non-drug-addicted patients with infective endocarditis and perivalvular abscess. J Heart Valve Dis. 2005;14:801–805.
    1. Carozza A, De Santo LS, Romano G, Della Corte A, Ursomando F, Scardone M, Caianiello G, Cotrufo M. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006;15:125–131.
    1. Tornos MP, Permanyer-Miralda G, Olona M, Gil M, Galve E, Almirante B, Soler-Soler J. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med. 1992;117:567–572.
    1. Langley SM, Alexiou C, Stafford HM, Dalrymple-Hay MJR, Haw MP, Livesey SA, Monro JL. Aortic valve replacement for endocarditis: determinants of early and late outcome. J Heart Valve Dis. 2000;9:697–704.
    1. Alexiou C, Langley SM, Stafford H, Haw MP, Livesey SA, Monro JL. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome. J Heart Valve Dis. 2000;9:327–334.
    1. Grûnenfelder J, Akins CW, Hilgenberg AD, Vlahakes GJ, Torchiana DF, Madsen JC, MacGillivray TE. Long-term results and determinants of mortality after surgery for native and prosthetic valve endocarditis. J Heart Valve Dis. 2001;10:694–702.
    1. Delahaye F, Ecochard R, de Gevigney G, Barjhoux C, Malquarti V, Saradarian W, Delaye J. The long term prognosis of infective endocarditis. Eur Heart J. 1995;16:48–53.
    1. Castillo JC, Anguita MP, Ramírez A, Siles JR, Torres F, Mesa D, Franco M, Muòoz I, Concha M, Vallés F. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart. 2000;83:525–530. doi: 10.1136/heart.83.5.525.
    1. Mansur AJ, Dal Bó CM, Fukushima JT, Issa VS, Grinberg M, Pomerantzeff PM. Relapses, recurrences, valve replacements, and mortality during the long-term follow- up after infective endocarditis. Am Heart J. 2001;141:78–86. doi: 10.1067/mhj.2001.111952.
    1. Netzer ROM, Altwegg SC, Zollinger E, Täuber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart. 2002;88:61–66. doi: 10.1136/heart.88.1.61.
    1. Heiro M, Helenius H, Hurme S, Savunen T, Engblom E, Nikoskelainen J, Kotilainen P. Short-term and one-year outcome of infective endocarditis in adult patients treated in a Finnish teaching hospital during 1980–2004. BMC Infect Dis. 2007;7:17. doi: 10.1186/1471-2334-7-78.
    1. Durack DT, Lukes AS, Bright DK, the Duke Endocarditis Service New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200–209. doi: 10.1016/0002-9343(94)90143-0.
    1. Heiro M, Nikoskelainen J, Hartiala JJ, Saraste MK, Kotilainen PM. Diagnosis of infective endocarditis. Sensitivity of the Duke vs von Reyn criteria. Arch Intern Med. 1998;158:18–24. doi: 10.1001/archinte.158.1.18.
    1. Heiro M, Helenius H, Mäkilä S, Savunen T, Engblom E, Nikoskelainen J, Kotilainen P. Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980–2004. Heart. 2006;92:1457–1462. doi: 10.1136/hrt.2005.084715.
    1. Heiro M, Helenius H, Sundell J, Koskinen P, Engblom E, Nikoskelainen J, Kotilainen P. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J. 2005;26:1873–1881. doi: 10.1093/eurheartj/ehi277.
    1. Kotilainen P, Heiro M, Jalava J, Rantakokko V, Nikoskelainen J, Nikkari S, Rantakokko-Jalava K. Aetiological diagnosis of infective endocarditis by direct amplification of rRNA genes from surgically removed valve tissue. An 11-year experience in a Finnish teachning hospital. Ann Med. 2006;38:263–273. doi: 10.1080/07853890600622119.
    1. Hart RG, Foster JW, Luther MF, Kanter MC. Stroke in infective endocarditis. Stroke. 1990;21:695–700.
    1. Røder BL, Wandall DA, Espersen F, Frimodt-Møller N, Skinhøj P, Rosdahl VT. Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med. 1997;102:379–386. doi: 10.1016/S0002-9343(97)00090-9.
    1. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P. Neurologic manifestations of infective endocarditis. A 17-year experience in a teaching hospital in Finland. Arch Intern Med. 2000;160:2781–2787. doi: 10.1001/archinte.160.18.2781.
    1. Malquarti V, Saradarian W, Etienne J, Milon H, Delahaye JP. Prognosis of native valve infective endocarditis: a review of 253 cases. Eur Heart J. 1984:11–20.
    1. Bishara J, Leibovici L, Gartman-Israel D, Sagie A, Kazakov A, Miroshnik E, Ashkenazi S, Pitlik S. Long-term outcome of infective endocarditis: the impact of early surgical intervention. Clin Infect Dis. 2001;33:1636–1643. doi: 10.1086/323785.
    1. Van der Meer JTM, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands. I. Patient characteristics. Arch Intern Med. 1992;152:1863–1868. doi: 10.1001/archinte.152.9.1863.
    1. Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briançon S, Leport C, Canton P. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis. 1995;20:501–506.
    1. Welton DE, Young JB, Gentry WO, Raizner AE, Alexander JK, Chahine RA, Miller RR. Recurrent infective endocarditis. Analysis of predisposing factors and clinical features. Am J Med. 1979;66:932–938. doi: 10.1016/0002-9343(79)90447-9.
    1. Verheul HA, van den Brink RB, van Vreeland T, Moulijn AC, Düren DR, Dunning AJ. Effects of changes in management of active infective endocarditis on outcome in a 25-year period. Am J Cardiol. 1993;72:682–687. doi: 10.1016/0002-9149(93)90885-G.

Source: PubMed

3
Abonnieren